Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$110.93M
Total Bought:
$39.85M
Total Sold:
$45.14M
Net Transaction:
-$5.30M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Springworks Therapeutics Inc54,692281,139+226,447$1.98M$12.41M11.18%+$10.43M
Verona Pharma Plc - AdrADS0139,067+139,067$0$8.83M7.96%+$8.83M
Soleno Therapeutics Inc87,629120,449+32,820$3.94M$8.61M7.76%+$4.67M
Axsome Therapeutics, Inc.(AXSM)66,66172,113+5,452$5.64M$8.41M7.58%+$2.77M
Tarsus Pharmaceuticals, Inc.(TARS)173,144127,932-45,212$9.59M$6.57M5.92%-$3.02M
Blueprint Medicines Corp55,89274,192+18,300$4.87M$6.57M5.92%+$1.69M
Insmed Incorporated(INSM)114,36085,110-29,250$7.90M$6.49M5.85%-$1.40M
Axsome Therapeutics, Inc.CALL(AXSM)050,000+50,000$0$5.83M5.26%+$5.83M
Trevi Therapeutics, Inc.(TRVI)781,489686,219-95,270$3.22M$4.32M3.89%+$1.10M
Praxis Precision Medicines, Inc.(PRAX)44,98295,582+50,600$3.46M$3.62M3.26%+$157.9K
Centessa Pharmaceuticals-AdrADS244,538243,086-1,452$4.10M$3.50M3.15%-$600.4K
Enliven Therapeutics Inc141,710169,774+28,064$3.19M$3.34M3.01%+$152.7K
Merus Nv116,79677,896-38,900$4.91M$3.28M2.96%-$1.63M
Geron Corporation(GERN)1,074,8242,056,637+981,813$3.80M$3.27M2.95%-$534.8K
CG Oncology, Inc.(CGON)174,048132,298-41,750$4.99M$3.24M2.92%-$1.75M
Atyr Pharma Inc699,730777,020+77,290$2.53M$2.35M2.12%-$186.4K
Tectonic Therapeutic, Inc.(TECX)0132,222+132,222$0$2.34M2.11%+$2.34M
Xenon Pharmaceuticals Inc.(XENE)129,29169,603-59,688$5.07M$2.34M2.11%-$2.73M
Mind Medicine Mindmed Inc330,275390,143+59,868$2.30M$2.28M2.06%-$16.4K
Edgewise Therapeutics, Inc.(EWTX)83,176102,650+19,474$2.22M$2.26M2.04%+$37.5K
Edgewise Therapeutics, Inc.CALL(EWTX)0100,000+100,000$0$2.20M1.98%+$2.20M
Janux Therapeutics, Inc.(JANX)90,29281,292-9,000$4.83M$2.19M1.98%-$2.64M
Dianthus Therapeutics, Inc.(DNTH)106,43480,584-25,850$2.32M$1.46M1.32%-$858.5K
Whitehawk Therapeutics, Inc.(WHWK)817,939817,9390$2.58M$1.46M1.31%-$1.12M
Korro Bio, Inc.(KRRO)70,67859,723-10,955$2.69M$1.04M0.94%-$1.65M
Promis Neurosciences Inc1,592,6051,484,699-107,906$1.51M$1.03M0.93%-$476.9K
Tyra Biosciences, Inc.(TYRA)175,063107,244-67,819$2.43M$997.4K0.90%-$1.44M
Context Therapeutics Inc.(CNTX)1,576,7621,157,448-419,314$1.66M$708.4K0.64%-$947.2K
89bio Inc317,8330-317,833$2.49M$0—-$2.49M
Alumis Inc445,2590-445,259$3.50M$0—-$3.50M
Climb Bio, Inc.(CLYM)760,2250-760,225$1.37M$0—-$1.37M
EyePoint, Inc.(EYPT)348,0000-348,000$2.59M$0—-$2.59M
Intra-Cellular Therapies Inc147,7500-147,750$12.34M$0—-$12.34M
Jasper Therapeutics, Inc.(JSPR)122,4240-122,424$2.62M$0—-$2.62M
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q1 2025 | TickerTrail